Standout Papers

MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage ... 2003 2026 2010 2018 1.8k
  1. MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer (2003)
    Ping Ji, Sven Diederichs et al. Oncogene
  2. The Novel Histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification System of Lung Adenocarcinoma Is a Stage-Independent Predictor of Survival (2012)
    Arne Warth, Thomas Muley et al. Journal of Clinical Oncology
  3. Early palliative care for adults with advanced cancer (2017)
    Markus W. Haun, Gerta Rücker et al. Cochrane Database of Systematic Reviews
  4. Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial (2012)
    Luis Paz‐Ares, Filippo de Marinis et al. The Lancet Oncology
  5. PARAMOUNT: Final Overall Survival Results of the Phase III Study of Maintenance Pemetrexed Versus Placebo Immediately After Induction Treatment With Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non–Small-Cell Lung Cancer (2013)
    Luis Paz‐Ares, Filippo de Marinis et al. Journal of Clinical Oncology
  6. When do we need to care about the caregiver? Supportive care needs, anxiety, and depression among informal caregivers of patients with cancer and cancer survivors (2015)
    Halina Sklenarova, Markus W. Haun et al. Cancer

Immediate Impact

2 by Nobel laureates 5 from Science/Nature 87 standout
Sub-graph 1 of 14

Citing Papers

Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities
2022 Standout

Works of Michael Thomas being referenced

A gene expression signature associated with B cells predicts benefit from immune checkpoint blockade in lung adenocarcinoma
2021

Author Peers

Author Last Decade Papers Cites
Michael Thomas 6502 5723 3454 3935 350 12.3k
Rebecca S. Heist 5914 6002 2139 4117 267 11.1k
Primo N. Lara 8262 6857 3422 5908 448 15.9k
Bella Kaufman 3582 7844 3160 4261 247 14.7k
Patrick Neven 4816 8402 4330 2731 486 15.2k
Nico van Zandwijk 8086 4706 3098 4323 296 14.5k
Sabino De Placido 4412 7699 3698 4332 376 13.7k
William J. Gradishar 2991 7953 3455 2936 344 12.8k
Hans Wildiers 3163 7289 3358 2679 382 14.1k
Marianne Paesmans 4331 7904 2186 2326 332 12.9k
Karen Kelly 8158 9181 1643 3287 380 14.4k

All Works

Loading papers...

Rankless by CCL
2026